newsfilter
← Latest News
PR Newswire·

Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption

TRIN
  • Trinity Capital Inc. committed $35 million in growth capital to Neuros Medical, Inc.
  • The funding supports the commercialization of Neuros Medical's FDA-approved Altius Direct Electrical Nerve Stimulation System & expansion into new markets.
  • The Altius system targets chronic phantom & residual limb pain by interrupting peripheral nerve signals without relying on continuous medication.
  • This investment provides financial flexibility as Neuros Medical scales operations for an underserved population of over two million U.S. patients with limb loss.
  • Trinity Capital has deployed more than $5.5 billion across over 463 investments since its 2008 inception.